Histological Subtypes Drive Distinct Prognostic Immune Signatures in Classical Hodgkin Lymphoma - Université de Rennes Accéder directement au contenu
Article Dans Une Revue Cancers Année : 2022

Histological Subtypes Drive Distinct Prognostic Immune Signatures in Classical Hodgkin Lymphoma

Hervé Ghesquières
  • Fonction : Auteur
  • PersonId : 1029367

Résumé

Despite the success of standard front-line chemotherapy, 20% of classical Hodgkin lymphoma (cHL) patients still relapse or have refractory disease (r/r), and a subset of them die due to disease progression. There is a critical lack of predictive factors for early identification of those r/r patients who may benefit from new therapeutic strategies. This study aimed to evaluate the dynamic expression of 586 immune-related genes in a cohort of 42 cHL patients including 30 r/r cHL after first-line chemotherapy. Gene expression profiling (GEP) using NanoString technology identified a 19-gene immune signature at diagnosis predictive of cHL relapse, but dependent on histological subtypes. Genes related to tumor survival were found upregulated while genes related to B-lineage were downregulated at diagnosis in r/r nodular sclerosis cHL. In contrast to the mixed-cellularity subtype, comparative GEP analyses between paired diagnosis/relapse biopsies of nodular sclerosis cHL showed 118 differentially expressed genes, supporting an immune contexture switch at relapse with upregulation of immunosuppressive cytokines, such as and , and downregulation of the T-cell co-stimulatory receptor . These results indicate that the predictive value of immune signature in cHL is strongly influenced by histological subtype which should be considered when assessing new immunotherapy target strategies.

Domaines

Cancer
Fichier principal
Vignette du fichier
cancers-14-04893-v2.pdf (1.83 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03830703 , version 1 (26-10-2022)

Licence

Paternité

Identifiants

Citer

Claire Lamaison, Juliette Ferrant, Pauline Gravelle, Alexandra Traverse Glehen, Hervé Ghesquières, et al.. Histological Subtypes Drive Distinct Prognostic Immune Signatures in Classical Hodgkin Lymphoma. Cancers, 2022, 14 (19), pp.4893. ⟨10.3390/cancers14194893⟩. ⟨hal-03830703⟩
36 Consultations
43 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More